OTC · Healthcare
ESCALON MEDICAL CORP (ESMC)
As-reported financials and recent SEC filings for ESCALON MEDICAL CORP, latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$12.0M
Net income
$105,525
Net margin
0.9%
Diluted EPS
$0.00
ROE
5.5%
P/E (TTM)
—
Market cap
—
Debt / equity
—
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $12.0M | $12.0M | $12.2M | $10.7M | $10.5M |
| Gross profit | $5.5M | $5.1M | $5.5M | $4.6M | $4.4M |
| Operating income | $133,217 | $-104,476 | $478,543 | $-470,063 | $-33,697 |
| Net income | $105,525 | $-125,261 | $456,826 | $18,081 | $-52,023 |
| Diluted EPS | $0.00 | $-0.01 | $0.01 | $0.00 | $-0.01 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
10-Q2026-05-15
View on EDGAR →SCHEDULE 13G2026-04-09
View on EDGAR →10-Q2026-02-17
View on EDGAR →8-K2026-01-29
View on EDGAR →10-Q2025-11-14
View on EDGAR →SCHEDULE 13G/A2025-10-06
View on EDGAR →10-K2025-09-29
View on EDGAR →SCHEDULE 13G/A2025-07-08
View on EDGAR →Largest Healthcare peers
Go deeper on ESMC
Search ESCALON MEDICAL CORP’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeOr check your whole portfolio free — no account needed.
Data sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.